A Non-Profit Pharma Nabs FDA Nod for Non-Prescription Naloxone Nasal Spray

The FDA approved RiVive, an over-the-counter version of naloxone nasal spray from Harm Reduction Therapeutics. It’s the second such approval from the FDA this year, following an affirmative decision in March for OTC Narcan.